148 related articles for article (PubMed ID: 28549350)
21. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
22. Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI001) with apoptosis-inducing mechanisms in breast cancer.
Liu B; Fu L; Zhang C; Zhang L; Zhang Y; Ouyang L; He G; Huang J
Oncotarget; 2015 Mar; 6(9):6762-75. PubMed ID: 25742792
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological inhibition of Rac1-PAK1 axis restores tamoxifen sensitivity in human resistant breast cancer cells.
Gonzalez N; Cardama GA; Comin MJ; Segatori VI; Pifano M; Alonso DF; Gomez DE; Menna PL
Cell Signal; 2017 Jan; 30():154-161. PubMed ID: 27939839
[TBL] [Abstract][Full Text] [Related]
24. The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1.
Wiedmann RM; von Schwarzenberg K; Palamidessi A; Schreiner L; Kubisch R; Liebl J; Schempp C; Trauner D; Vereb G; Zahler S; Wagner E; Müller R; Scita G; Vollmar AM
Cancer Res; 2012 Nov; 72(22):5976-87. PubMed ID: 22986742
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix, Rac1 signaling, and estrogen-induced proliferation in MCF-7 breast cancer cells.
Xie JW; Haslam SZ
Breast Cancer Res Treat; 2008 Jul; 110(2):257-68. PubMed ID: 17851761
[TBL] [Abstract][Full Text] [Related]
26. Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway.
Jiao D; Zhang XD
Oncol Rep; 2016 Jul; 36(1):342-8. PubMed ID: 27122002
[TBL] [Abstract][Full Text] [Related]
27. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
[TBL] [Abstract][Full Text] [Related]
28. Rac1 promotes chondrogenesis by regulating STAT3 signaling pathway.
Kim H; Sonn JK
Cell Biol Int; 2016 Sep; 40(9):976-83. PubMed ID: 27306109
[TBL] [Abstract][Full Text] [Related]
29. Biphasic dose-dependent effect of lithium chloride on survival of human hormone-dependent breast cancer cells (MCF-7).
Suganthi M; Sangeetha G; Gayathri G; Ravi Sankar B
Biol Trace Elem Res; 2012 Dec; 150(1-3):477-86. PubMed ID: 23054864
[TBL] [Abstract][Full Text] [Related]
30. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
31. Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer.
Dey G; Bharti R; Dhanarajan G; Das S; Dey KK; Kumar BN; Sen R; Mandal M
Sci Rep; 2015 May; 5():10316. PubMed ID: 25974307
[TBL] [Abstract][Full Text] [Related]
32. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
33. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
[TBL] [Abstract][Full Text] [Related]
34. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
[TBL] [Abstract][Full Text] [Related]
35. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment.
Hein AL; Post CM; Sheinin YM; Lakshmanan I; Natarajan A; Enke CA; Batra SK; Ouellette MM; Yan Y
Oncogene; 2016 Dec; 35(49):6319-6329. PubMed ID: 27181206
[TBL] [Abstract][Full Text] [Related]
36. Sugiol inhibits STAT3 activity via regulation of transketolase and ROS-mediated ERK activation in DU145 prostate carcinoma cells.
Jung SN; Shin DS; Kim HN; Jeon YJ; Yun J; Lee YJ; Kang JS; Han DC; Kwon BM
Biochem Pharmacol; 2015 Sep; 97(1):38-50. PubMed ID: 26212545
[TBL] [Abstract][Full Text] [Related]
37. Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway.
Lin CH; Yu MC; Tung WH; Chen TT; Yu CC; Weng CM; Tsai YJ; Bai KJ; Hong CY; Chien MH; Chen BC
Biochim Biophys Acta; 2013 Dec; 1833(12):2823-2833. PubMed ID: 23906792
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of phospholipase D enhances Bcl-2 expression by activating STAT3 through independent activation of ERK and p38MAPK in HeLa cells.
Choi HJ; Han JS
Biochim Biophys Acta; 2012 Jun; 1823(6):1082-91. PubMed ID: 22504301
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]